Previous 10 | Next 10 |
home / stock / rx:cc / rx:cc news
MISSISSAUGA, Ontario, Feb. 21, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that it has been named to the 2024 TSX Venture 50 list as one of the top performers on the TSX Venture Exchange. The TSX Vent...
MISSISSAUGA, Ontario, Feb. 06, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.045 per common share, payable in Canadian Dollars on March 15, ...
MISSISSAUGA, Ontario, Nov. 20, 2023 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its subsidiary, BioSyent Pharma Inc., has commenced the first shipments of its new oncology supportive care product, Gelclair ...
MISSISSAUGA, Ontario, Nov. 16, 2023 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three months (Q3) and nine months (YTD) ended September 30, 2023. Key highlights include: Return on Equity for the Trailing Twelve...
MISSISSAUGA, Ontario, Nov. 15, 2023 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.04 per common share, payable in Canadian Dollars on December 15...
Mapath Capital Corp. (MPTH.H:CA) is expected to report for Q1 2024 Essential Energy Services Ltd. (ESN:CA) is expected to report for Q1 2024 Next Hydrogen Solutions Inc. (NXH:CA) is expected to report for Q1 2024 Osisko Mining Inc. (OSK:CA) is expected to report $-0.02 for Q3 2023 ...
BioSyent Inc. (RX:CA) is expected to report $0.1 for Q3 2023
MISSISSAUGA, Ontario, Nov. 09, 2023 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three and nine months ended September 30, 2023 on Thursday, November 16, 2023 before market hours. A prese...
MISSISSAUGA, Ontario, Oct. 18, 2023 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce the launch of menopauseinformation.ca , a comprehensive online platform designed to empower peri-menopausal and menopausal women across Canada. Menopa...
2023-09-06 20:00:00 ET Biosyent is now ranked among the top 10 undervalued small cap dividend-paying stocks on the TSX Venture Exchange (TSX-V). A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true...
News, Short Squeeze, Breakout and More Instantly...
Biosyent Inc. Company Name:
RX:CC Stock Symbol:
TSXVC Market:
MISSISSAUGA, Ontario, May 16, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three months (Q1) ended March 31, 2024. Key highlights include: Return on Equity for TTM March 31, 2024 was 21% as compared to 15% ...
MISSISSAUGA, Ontario, May 16, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.045 per common share, payable in Canadian Dollars on June 15, 20...
BioSyent Inc. (RX:CA) is expected to report $0.08 for Q1 2024 Heroux-Devtek Inc. (HRX:CA) is expected to report $0.31 for Q4 2024 Lightspeed Commerce Inc. Subordinate Voting Shares (LSPD:CA) is expected to report $-0.23 for Q4 2024 Abcourt Mines Inc. (ABI:CA) is expected to report for...